Switch to:
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Cash Flow from Operations
$3,211 Mil (TTM As of Jun. 2014)

Cash flow from operations refers to the cash brought in through a company’'s normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Jun. 2014, Teva Pharmaceutical Industries Ltd's Net Income From Continuing Operations was $745 Mil. Its DDA was $778 Mil. Its Change In Working Capital was $-89 Mil. Its cash flow from deferred tax was $-124 Mil. Its Cash Flow from Discontinued Operations was $0 Mil. And its Cash Flow from Others was $-257 Mil. In all, Teva Pharmaceutical Industries Ltd's Cash Flow from Operations for the three months ended in Jun. 2014 was $1,053 Mil.


Definition

Cash flow from operations refers to the cash brought in through a company’'s normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Teva Pharmaceutical Industries Ltd's Cash Flow from Operations for the fiscal year that ended in Dec. 2013 is calculated as:

Teva Pharmaceutical Industries Ltd's Cash Flow from Operations for the quarter that ended in Jun. 2014 is

Teva Pharmaceutical Industries Ltd Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2014 was 444 (Sep. 2013 ) + 816 (Dec. 2013 ) + 898 (Mar. 2014 ) + 1053 (Jun. 2014 ) = $3,211 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

Cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Teva Pharmaceutical Industries Ltd's net income from continuing operations for the three months ended in Jun. 2014 was $745 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
• The term “depreciation” is used when discussing man made tangible assets
• The term “depletion” is used when discussing natural tangible assets
• The term “amortization” is used when discussing intangible assets

Teva Pharmaceutical Industries Ltd's depreciation, depletion and amortization for the three months ended in Jun. 2014 was $778 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Teva Pharmaceutical Industries Ltd's change in working capital for the three months ended in Jun. 2014 was $-89 Mil. It means Teva Pharmaceutical Industries Ltd's working capital declined by $89 Mil from Mar. 2014 to Jun. 2014 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Teva Pharmaceutical Industries Ltd's cash flow from deferred tax for the three months ended in Jun. 2014 was $-124 Mil.

5. Cash Flow from Discontinued Operations:
Cash received by a company that comes from the sale of part of business.

Teva Pharmaceutical Industries Ltd's cash flow from discontinued operations for the three months ended in Jun. 2014 was $0 Mil.

6. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Teva Pharmaceutical Industries Ltd's cash flow from others for the three months ended in Jun. 2014 was $-257 Mil.


Related Terms

Net Income From Continuing Operations, Depreciation, Depletion and Amortization, Change In Working Capital, Cash Flow from Discontinued Operations, Cash Flow from Others, Cash Flow from Investing


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Teva Pharmaceutical Industries Ltd Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
NetIncomeFromContinuingOperations 3321,0725461,9526352,0043,3392,7681,9101,253
CF_DDA 2182434315214939089771,0691,7081,642
ChangeInWorkingCapital 3089-218-85476445-205594414968
CF_DeferredTax 27-7-8911127-140-199-500-690-1,380
Cash Flow from Disc. Op. 0000000000
Cash Flow from Others 639-271,388832,0001562242031,230754
Cash Flow from Operations 1,2461,3702,0581,8133,2313,3734,1364,1344,5723,237

Teva Pharmaceutical Industries Ltd Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
NetIncomeFromContinuingOperations 855859-84280626-456706377740745
CF_DDA 5193844121,2963874004191,2230778
ChangeInWorkingCapital -277-179422448601,150-601359-248-89
CF_DeferredTax -40695-192-498-100-337-229-1,1510-124
Cash Flow from Disc. Op. 0000000000
Cash Flow from Others 6532490511291181498406-257
Cash Flow from Operations 7561,1911,0481,5771,1028754448168981,053
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide